×
Hero Background

Dermatophytic Onychomycosis Treatment Companies

ID: MRFR/HC/10012-HCR
128 Pages
Kinjoll Dey
October 2025

Addressing fungal nail infections, Dermatophytic Onychomycosis Treatment companies specialize in developing effective therapies. Through research and innovation, they offer treatments that combat dermatophytes, providing patients with solutions to manage and eradicate onychomycosis, promoting healthier nails and improved quality of life.

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Dermatophytic Onychomycosis Treatment Market Research Report—Global Forecast till 2035 Infographic
Summary Table of Contents Segmentation Download PDF

Top Industry Leaders in the Dermatophytic Onychomycosis Treatment Market

Dermatophytic Onychomycosis Treatment Key Companies

 


Latest Dermatophytic Onychomycosis Treatment Companies Update:

Alembic Pharmaceuticals Limited: In April 2023, Alembic received tentative FDA approval for its Efinaconazole Topical Solution, a new antifungal treatment for onychomycosis. This could significantly expand their market reach.


Lucira Therapeutics: In December 2023, Lucira announced positive Phase 3 trial results for its LCLX-101, a novel topical antifungal treatment for onychomycosis. This could potentially usher in a new class of treatments.


Bausch Health Companies Inc.: In September 2023, Bausch Health announced a partnership with Pfizer to develop and commercialize a new oral antifungal medication for onychomycosis. This collaboration combines expertise from two major players in the market.


Galderma: In July 2023, Galderma launched a new topical antifungal cream for onychomycosis, Kerydin MAX. This new formulation offers improved efficacy and patient comfort.


List of Dermatophytic Onychomycosis Treatment Key companies in the market

  • Bausch Health Companies Inc.

  • Pfizer Inc.

  • Galderma

  • GlaxoSmithKline plc

  • Janssen Pharmaceuticals, Inc.

  • Cipla Inc.

  • Kaken pharmaceuticals Co., Ltd.